The store will not work correctly when cookies are disabled.
1-(3-Methylbenzoyl)-5-propionylamino-1H-indazole-3-carboxylic Acid ethyl ester
ID: ALA2409571
PubChem CID: 71818832
Max Phase: Preclinical
Molecular Formula: C21H21N3O4
Molecular Weight: 379.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1nn(C(=O)c2cccc(C)c2)c2ccc(NC(=O)CC)cc12
Standard InChI: InChI=1S/C21H21N3O4/c1-4-18(25)22-15-9-10-17-16(12-15)19(21(27)28-5-2)23-24(17)20(26)14-8-6-7-13(3)11-14/h6-12H,4-5H2,1-3H3,(H,22,25)
Standard InChI Key: WMTQOTNFTZMUKV-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
17.3660 -18.3249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3648 -19.1444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0729 -19.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0711 -17.9160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7797 -18.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7799 -19.1444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5612 -19.4013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0466 -18.7325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5622 -18.0673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5476 -20.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8325 -20.6125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2477 -20.6384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2305 -21.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9298 -21.8755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6459 -21.4798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6582 -20.6585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9583 -20.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9365 -17.3408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7527 -17.3018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1947 -17.9892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4945 -16.6535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.3719 -20.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0109 -17.9501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6582 -17.9164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9505 -18.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2427 -17.9168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9507 -19.1424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5351 -18.3255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
16 22 1 0
20 23 1 0
1 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.42 | Molecular Weight (Monoisotopic): 379.1532 | AlogP: 3.56 | #Rotatable Bonds: 5 |
Polar Surface Area: 90.29 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.90 | CX Basic pKa: ┄ | CX LogP: 3.47 | CX LogD: 3.47 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.68 | Np Likeness Score: -1.73 |
References
1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670] [10.1021/jm400742j] |